Northwestern faculty elected to Society for Clinical Trials board

Masha Kocherginsky, PhD, professor of preventive medicine in the division of biostatistics, has been elected to the board of directors of the Society for Clinical Trials (SCT).

Jody Ciolino, PhD, associate professor of preventive medicine in the Division of Biostatistics, and Masha Kocherginsky, PhD, professor of preventive medicine in the Division of Biostatistics, were both elected to the Board of Directors of the Society for Clinical Trials (SCT ) .

The TBS is an international organization dedicated to developing and disseminating knowledge about the design, conduct, analysis and reporting of clinical trials and related healthcare research methodologies.

“It is truly a great honor to be elected by the members of society and to have this incredible opportunity to contribute back to society, which has had a great positive impact on my professional development as a statistician working in clinical trials,” Kocherginsky said. , who is also a professor of obstetrics and gynecology in the division of gynecologic oncology.

“To have the society, including such well-known and respected mentors and researchers, appoint me to the board of directors is truly an honor,” said Ciolino, who is also an associate professor of medicine in the Division of general internal medicine. Medicine.

Kocherginsky’s main interest is the design and analysis of clinical trials. She is the Director of the Quantitative Data Sciences Core (QDSC) at Northwestern University’s Robert H. Lurie Comprehensive Cancer Center, a shared resource that provides support to cancer scientists in the areas of biostatistics, bioinformatics, and computer science. clinical. At TBS, she said she plans to expand education opportunities, mentoring and leadership training.

Jody Ciolino, PhD, associate professor of preventive medicine in the division of biostatistics, has been elected to the board of directors of the Society for Clinical Trials (SCT).

“I view TBS as the primary platform for disseminating and promoting cutting-edge methodologies in clinical trials, and a place to help its members enhance their professional development, relationships and leadership skills,” Kocherginsky said. .

Ciolino is a member of Northwestern University’s Data Analysis and Coordination Center (NUDACC) and director of the Master of Science in Biostatistics program. While TBS has made progress on equity, diversity and inclusion, Ciolino says she would like to see the organization go further.

“Recognizing that these efforts are really just small steps towards the larger goal of embedding equity, diversity and inclusiveness within society, I would like to make sure that every step forward is a good one, that these small steps have the potential to make great progress and lasting impact and recognize that the work in this area will never be ‘complete,'” Ciolino said. “Through my role at SCT, I hope continue to drive initiatives forward, striving to find innovative ways to attract new and diverse members to create a sustainable society.”

Ciolino and Kocherginsky are both members of the Biostatistics Collaboration Center (BCC).

About Terry Gongora

Check Also

Strata Oncology Senior Vice President of Clinical Development Kat Kwiatkowski to Participate in Two Panels at the Precision Medicine World Conference

Title: Removing Barriers to Biomarker Testing Through Collaboration Time: Tuesday, June 28 at 9:00 a.m. …